John G Lemkey is Chief Operating Officer of Odonate Therapeutics, Inc.. Currently has a direct ownership of 3,457 shares of ODTC, which is worth approximately $58.9 Million. The most recent transaction as insider was on Nov 30, 2020, when has been sold 12 shares (Common Stock) at a price of $12.77 per share, resulting in proceeds of $153. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.46K
0% 3M change
0% 12M change
Total Value Held $58.9 Million

John G Lemkey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2020
BUY
Grant, award, or other acquisition
$153 $12.77 p/Share
12 Added 0.35%
3,457 Common Stock
Nov 13 2020
BUY
Grant, award, or other acquisition
$1,171 $12.2 p/Share
96 Added 2.71%
3,445 Common Stock
Oct 30 2020
BUY
Grant, award, or other acquisition
$1,176 $12.25 p/Share
96 Added 2.79%
3,349 Common Stock
Oct 15 2020
BUY
Grant, award, or other acquisition
$1,175 $13.35 p/Share
88 Added 2.63%
3,253 Common Stock
Sep 30 2020
BUY
Grant, award, or other acquisition
$1,165 $11.42 p/Share
102 Added 3.12%
3,165 Common Stock
JGL

John G Lemkey

Chief Operating Officer
San Diego, CA

Track Institutional and Insider Activities on ODTC

Follow Odonate Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ODTC shares.

Notify only if

Insider Trading

Get notified when an Odonate Therapeutics, Inc. insider buys or sells ODTC shares.

Notify only if

News

Receive news related to Odonate Therapeutics, Inc.

Track Activities on ODTC